JP2021123540A - Skin external agent - Google Patents
Skin external agent Download PDFInfo
- Publication number
- JP2021123540A JP2021123540A JP2020016095A JP2020016095A JP2021123540A JP 2021123540 A JP2021123540 A JP 2021123540A JP 2020016095 A JP2020016095 A JP 2020016095A JP 2020016095 A JP2020016095 A JP 2020016095A JP 2021123540 A JP2021123540 A JP 2021123540A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- group
- mass
- carbon atoms
- glyceryl glucoside
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 glyceryl glucoside Chemical class 0.000 claims abstract description 56
- 229930182478 glucoside Natural products 0.000 claims abstract description 28
- 229920000642 polymer Polymers 0.000 claims abstract description 24
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 23
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims abstract description 21
- 229960000401 tranexamic acid Drugs 0.000 claims abstract description 21
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 20
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 20
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims abstract description 14
- 150000002148 esters Chemical class 0.000 claims abstract description 14
- 125000005702 oxyalkylene group Chemical group 0.000 claims abstract description 13
- 150000001875 compounds Chemical class 0.000 claims abstract description 12
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000006116 polymerization reaction Methods 0.000 claims abstract description 11
- 150000003839 salts Chemical class 0.000 claims abstract description 8
- NJNWCIAPVGRBHO-UHFFFAOYSA-N 2-hydroxyethyl-dimethyl-[(oxo-$l^{5}-phosphanylidyne)methyl]azanium Chemical group OCC[N+](C)(C)C#P=O NJNWCIAPVGRBHO-UHFFFAOYSA-N 0.000 claims abstract description 6
- 125000006353 oxyethylene group Chemical group 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims description 22
- 230000003020 moisturizing effect Effects 0.000 abstract description 17
- 239000003795 chemical substances by application Substances 0.000 abstract description 7
- 239000004909 Moisturizer Substances 0.000 abstract description 3
- 230000001333 moisturizer Effects 0.000 abstract description 3
- 229920000223 polyglycerol Polymers 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 53
- 235000011187 glycerol Nutrition 0.000 description 26
- 210000003491 skin Anatomy 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 21
- 239000000178 monomer Substances 0.000 description 21
- HQHCYKULIHKCEB-UHFFFAOYSA-N tetradecanedioic acid Chemical compound OC(=O)CCCCCCCCCCCCC(O)=O HQHCYKULIHKCEB-UHFFFAOYSA-N 0.000 description 19
- JJOJFIHJIRWASH-UHFFFAOYSA-N Eicosanedioic acid Natural products OC(=O)CCCCCCCCCCCCCCCCCCC(O)=O JJOJFIHJIRWASH-UHFFFAOYSA-N 0.000 description 15
- 239000008213 purified water Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- 239000003205 fragrance Substances 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 229920001451 polypropylene glycol Polymers 0.000 description 8
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 229920001223 polyethylene glycol Polymers 0.000 description 7
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 6
- ZSZRUEAFVQITHH-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethyl 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CC(=C)C(=O)OCCOP([O-])(=O)OCC[N+](C)(C)C ZSZRUEAFVQITHH-UHFFFAOYSA-N 0.000 description 6
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 229940031439 squalene Drugs 0.000 description 6
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 6
- 210000000434 stratum corneum Anatomy 0.000 description 6
- SOGAXMICEFXMKE-UHFFFAOYSA-N alpha-Methyl-n-butyl acrylate Natural products CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 229920001748 polybutylene Polymers 0.000 description 5
- 230000036572 transepidermal water loss Effects 0.000 description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 150000001735 carboxylic acids Chemical class 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 210000000245 forearm Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 3
- BTZVDPWKGXMQFW-UHFFFAOYSA-N Pentadecanedioic acid Chemical compound OC(=O)CCCCCCCCCCCCCC(O)=O BTZVDPWKGXMQFW-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- QQHJDPROMQRDLA-UHFFFAOYSA-N hexadecanedioic acid Chemical compound OC(=O)CCCCCCCCCCCCCCC(O)=O QQHJDPROMQRDLA-UHFFFAOYSA-N 0.000 description 3
- BNJOQKFENDDGSC-UHFFFAOYSA-N octadecanedioic acid Chemical compound OC(=O)CCCCCCCCCCCCCCCCC(O)=O BNJOQKFENDDGSC-UHFFFAOYSA-N 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- JHRJYXZOXJXEJJ-UHFFFAOYSA-N 8-ethyloctadecanedioic acid Chemical compound OC(=O)CCCCCCC(CC)CCCCCCCCCC(O)=O JHRJYXZOXJXEJJ-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000009697 arginine Nutrition 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- TVIDDXQYHWJXFK-UHFFFAOYSA-N dodecanedioic acid Chemical compound OC(=O)CCCCCCCCCCC(O)=O TVIDDXQYHWJXFK-UHFFFAOYSA-N 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 125000003709 fluoroalkyl group Chemical group 0.000 description 2
- 238000010528 free radical solution polymerization reaction Methods 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 235000019866 hydrogenated palm kernel oil Nutrition 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- CBFCDTFDPHXCNY-UHFFFAOYSA-N icosane Chemical compound CCCCCCCCCCCCCCCCCCCC CBFCDTFDPHXCNY-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- TYFQFVWCELRYAO-UHFFFAOYSA-N suberic acid Chemical compound OC(=O)CCCCCCC(O)=O TYFQFVWCELRYAO-UHFFFAOYSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- LWBHHRRTOZQPDM-UHFFFAOYSA-N undecanedioic acid Chemical compound OC(=O)CCCCCCCCCC(O)=O LWBHHRRTOZQPDM-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- XNPQQOIJPDOCIH-UHFFFAOYSA-N 2,2-dimethylicosanedioic acid Chemical compound OC(=O)C(C)(C)CCCCCCCCCCCCCCCCCC(O)=O XNPQQOIJPDOCIH-UHFFFAOYSA-N 0.000 description 1
- CEAKZVDHZILFGK-UHFFFAOYSA-N 2,4-diethylpentanedioic acid Chemical compound CCC(C(O)=O)CC(CC)C(O)=O CEAKZVDHZILFGK-UHFFFAOYSA-N 0.000 description 1
- AVBJHQDHVYGQLS-UHFFFAOYSA-N 2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)NC(C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-UHFFFAOYSA-N 0.000 description 1
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- HOSGXJWQVBHGLT-UHFFFAOYSA-N 6-hydroxy-3,4-dihydro-1h-quinolin-2-one Chemical group N1C(=O)CCC2=CC(O)=CC=C21 HOSGXJWQVBHGLT-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 241000207836 Olea <angiosperm> Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 238000012644 addition polymerization Methods 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- QYQADNCHXSEGJT-UHFFFAOYSA-N cyclohexane-1,1-dicarboxylate;hydron Chemical compound OC(=O)C1(C(O)=O)CCCCC1 QYQADNCHXSEGJT-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229940074052 glyceryl isostearate Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000011968 lewis acid catalyst Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- HLERILKGMXJNBU-UHFFFAOYSA-N norvaline betaine Chemical compound CCCC(C([O-])=O)[N+](C)(C)C HLERILKGMXJNBU-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000003444 phase transfer catalyst Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000007870 radical polymerization initiator Substances 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000010557 suspension polymerization reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- DXNCZXXFRKPEPY-UHFFFAOYSA-N tridecanedioic acid Chemical compound OC(=O)CCCCCCCCCCCC(O)=O DXNCZXXFRKPEPY-UHFFFAOYSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Description
本発明は、皮膚外用剤に関する。 The present invention relates to an external preparation for skin.
トラネキサム酸は保湿作用、美白作用等の作用を有することから化粧品の有効成分として用いられている(特許文献1)。また、グリセリルグルコシドは高い保湿効果を有し、皮膚外用剤に配合されることがよく知られている(特許文献2)。しかしながら、グリセリルグルコシドを保湿有効成分量配合すると、使用感上べたつくという課題があった。そこで種々の成分との併用が検討されているが、その保湿効果は限定的であった。 Tranexamic acid is used as an active ingredient in cosmetics because it has moisturizing and whitening effects (Patent Document 1). In addition, glyceryl glucoside has a high moisturizing effect, and it is well known that it is blended in an external preparation for skin (Patent Document 2). However, when glyceryl glucoside is blended in an amount of a moisturizing active ingredient, there is a problem that it is sticky in terms of usability. Therefore, the combined use with various components has been studied, but its moisturizing effect has been limited.
本発明は、トラネキサム酸又はその塩、グリセリルグルコシド及び特定の保湿剤から選択される1種又は2種以上を併用することにより、保湿効果が相乗的に向上する皮膚外用剤を提供することを課題とする。 An object of the present invention is to provide a skin external preparation having a synergistically improved moisturizing effect by using one or more selected from tranexamic acid or a salt thereof, glyceryl glucoside and a specific moisturizing agent in combination. And.
本発明は、下記(A)〜(C)を含有する皮膚外用剤
(A)トラネキサム酸又はその塩
(B)グリセリルグルコシド
(C)二価カルボン酸及び平均重合度2以上15以下のポリグリセリンから構成されるオリゴマーエステル、ホスホリルコリン基含有重合体、トリメチルグリシン、並びに下記式(2)
Z−{O(AO)l(EO)m−(BO)nH}a …式(2)
(式中、
Zは3〜9個の水酸基を有する化合物の水酸基を除いた残基を表し;
AOは炭素数3〜4のオキシアルキレン基を表し;
EOはオキシエチレン基を表し;BOは炭素数4のオキシアルキレン基を表し;
aは3〜9を表し;
l、m及びnは、それぞれ、AO、EO及びBOの平均付加モル数であって、1≦l≦50、1≦m≦50及び0.5≦n≦5であり;
AOとEOとの重量比(AO/EO)は1/5〜5/1であり;
AO及びEOはランダム状又はブロック状に付加されてもよい。)
で表される少なくとも1つのアルキレンオキシド誘導体から選択される1種又は2種以上
を提供する。
The present invention comprises a skin external preparation (A) tranexamic acid or a salt thereof (B) glyceryl glucoside (C) divalent carboxylic acid containing the following (A) to (C) and polyglycerin having an average degree of polymerization of 2 or more and 15 or less. Consists of oligomeric ester, phosphorylcholine group-containing polymer, trimethylglycin, and the following formula (2)
Z- {O (AO) l (EO) m- (BO) n H} a ... Equation (2)
(During the ceremony,
Z represents the residue of the compound having 3 to 9 hydroxyl groups excluding the hydroxyl group;
AO represents an oxyalkylene group having 3 to 4 carbon atoms;
EO represents an oxyethylene group; BO represents an oxyalkylene group having 4 carbon atoms;
a represents 3-9;
l, m and n are the average number of moles of AO, EO and BO, respectively, 1 ≦ l ≦ 50, 1 ≦ m ≦ 50 and 0.5 ≦ n ≦ 5.
The weight ratio of AO to EO (AO / EO) is 1/5 to 5/1;
AO and EO may be added randomly or in blocks. )
Provided is one or more selected from at least one alkylene oxide derivative represented by.
本発明の皮膚外用剤は、トラネキサム酸又はその塩、グリセリルグルコシド及び特定の保湿剤から選択される1種又は2種以上を併用することにより、保湿効果が相乗的に向上する。 The skin external preparation of the present invention synergistically improves the moisturizing effect by using one or more selected from tranexamic acid or a salt thereof, glyceryl glucoside and a specific moisturizing agent in combination.
以下本発明を実施するための形態を説明する。 Hereinafter, embodiments for carrying out the present invention will be described.
本発明の皮膚外用剤は、化粧品、医薬部外品、医薬品等のいずれの用途にも用いられ得る。 The external preparation for skin of the present invention can be used for any of cosmetics, quasi-drugs, pharmaceuticals and the like.
トラネキサム酸又はその塩は、一般的に化粧料等に用いられているものであればよい。市販品としては、トラネキサム酸(日本精化株式会社)等が挙げられる。本発明の皮膚外用剤への配合量としては、皮膚外用剤全量に対し0.01〜5質量%が好ましく、1〜2.5質量%がより好ましく、1〜2質量%が最も好ましい。 Tranexamic acid or a salt thereof may be any as long as it is generally used for cosmetics and the like. Examples of commercially available products include tranexamic acid (Nippon Fine Chemical Co., Ltd.). The blending amount of the present invention in the external preparation for skin is preferably 0.01 to 5% by mass, more preferably 1 to 2.5% by mass, and most preferably 1 to 2% by mass with respect to the total amount of the external preparation for skin.
グリセリルグルコシドは、一般的に化粧料等に配合し得るものであれば製造方法は、合成、微生物による発酵等方法を問わない。具体的には、α体、β体、或いはこれらの混合物のいずれも用いることができる。市販品としては、αGG(登録商標)−L(辰馬本家酒造株式会社)、COSARTE−2G(登録商標)(東洋精糖株式会社)等が挙げられる。 As long as the glyceryl glucoside can be generally blended in cosmetics and the like, the production method may be any method such as synthesis or fermentation by microorganisms. Specifically, any of α-form, β-form, or a mixture thereof can be used. Examples of commercially available products include αGG (registered trademark) -L (Tatsuuma Honke Sake Brewery Co., Ltd.) and COSARTE-2G (registered trademark) (Toyo Sugar Refining Co., Ltd.).
本発明の皮膚外用剤へのグリセリルグルコシドの配合量は、皮膚外用剤全量に対し0.001〜5質量%が好ましく、0.001〜3質量%がさらに好ましい。グリセリルグルコシドの配合量が0.001質量%未満では、十分な保湿効果が得られない場合がある。グリセリルグルコシドの配合量が5質量%を超えると、べたつきの原因となる場合がある。 The blending amount of glyceryl glucoside in the external preparation for skin of the present invention is preferably 0.001 to 5% by mass, more preferably 0.001 to 3% by mass, based on the total amount of the external preparation for skin. If the blending amount of glyceryl glucoside is less than 0.001% by mass, a sufficient moisturizing effect may not be obtained. If the blending amount of glyceryl glucoside exceeds 5% by mass, it may cause stickiness.
本発明において特定の保湿剤とは、二価カルボン酸及び平均重合度2以上15以下のポリグリセリンから構成されるオリゴマーエステル、ホスホリルコリン基含有重合体、トリメチルグリシン、並びに下記式(2)
Z−{O(AO)l(EO)m−(BO)nH}a …式(2)
(式中、
Zは3〜9個の水酸基を有する化合物の水酸基を除いた残基を表し;
AOは炭素数3〜4のオキシアルキレン基を表し;
EOはオキシエチレン基を表し;BOは炭素数4のオキシアルキレン基を表し;
aは3〜9を表し;
l、m及びnは、それぞれ、AO、EO及びBOの平均付加モル数であって、1≦l≦50、1≦m≦50及び0.5≦n≦5であり;
AOとEOとの重量比(AO/EO)は1/5〜5/1であり;
AO及びEOはランダム状又はブロック状に付加されてもよい。)
で表される少なくとも1つのアルキレンオキシド誘導体から選択される1種又は2種以上である。
In the present invention, the specific moisturizer is an oligomer ester composed of a divalent carboxylic acid and polyglycerin having an average degree of polymerization of 2 or more and 15 or less, a phosphorylcholine group-containing polymer, trimethylglycine, and the following formula (2).
Z- {O (AO) l (EO) m- (BO) n H} a ... Equation (2)
(During the ceremony,
Z represents the residue of the compound having 3 to 9 hydroxyl groups excluding the hydroxyl group;
AO represents an oxyalkylene group having 3 to 4 carbon atoms;
EO represents an oxyethylene group; BO represents an oxyalkylene group having 4 carbon atoms;
a represents 3-9;
l, m and n are the average number of moles of AO, EO and BO, respectively, 1 ≦ l ≦ 50, 1 ≦ m ≦ 50 and 0.5 ≦ n ≦ 5.
The weight ratio of AO to EO (AO / EO) is 1/5 to 5/1;
AO and EO may be added randomly or in blocks. )
One or more selected from at least one alkylene oxide derivative represented by.
二価カルボン酸及び平均重合度2以上15以下のポリグリセリンから構成されるオリゴマーエステルの二価カルボン酸としては、直鎖、分岐鎖、或いは環状構造の何れかを含む二価カルボン酸であれば特に限定されないが、合成のしやすさ、保湿効果を向上させる観点から、二価カルボン酸の炭素数は、好ましくは2以上、より好ましくは8以上、更に好ましくは12以上、更に好ましくは14以上であって、好ましくは26以下、より好ましくは24以下、更に好ましくは22以下、更に好ましくは20以下である。また、同様の観点から、脂肪族二価カルボン酸が好ましい。具体的な炭素数2以上26以下の二価カルボン酸としては、例えば、アジピン酸、ピメリン酸、スベリン酸、アゼライン酸、セバシン酸、2,4−ジエチルペンタン二酸、ウンデカン二酸、ドデカン二酸、トリデカン二酸、テトラデカン二酸、ペンタデカン二酸、ヘキサデカン二酸、オクタデカン二酸、8−エチルオクタデカン二酸、エイコサン二酸、ジメチルエイコサン二酸、シクロヘキサンジカルボン酸等が挙げられる。これら二価カルボン酸は、いずれか1種を単独で、又は2種以上を適宜組合せて用いることができる。 The divalent carboxylic acid of the oligomer ester composed of the divalent carboxylic acid and the polyglycerin having an average degree of polymerization of 2 or more and 15 or less is a divalent carboxylic acid containing any of a straight chain, a branched chain, and a cyclic structure. Although not particularly limited, the number of carbon atoms of the divalent carboxylic acid is preferably 2 or more, more preferably 8 or more, still more preferably 12 or more, still more preferably 14 or more, from the viewpoint of improving the ease of synthesis and the moisturizing effect. It is preferably 26 or less, more preferably 24 or less, still more preferably 22 or less, still more preferably 20 or less. From the same viewpoint, an aliphatic divalent carboxylic acid is preferable. Specific divalent carboxylic acids having 2 or more and 26 or less carbon atoms include, for example, adipic acid, pimelliic acid, suberic acid, azelaic acid, sebacic acid, 2,4-diethylpentanedioic acid, undecanedioic acid, and dodecanedioic acid. , Tridecanedioic acid, tetradecanedioic acid, pentadecanedioic acid, hexadecanedioic acid, octadecanedioic acid, 8-ethyloctadecandioic acid, eicosandioic acid, dimethyleicosanedioic acid, cyclohexanedicarboxylic acid and the like. Any one of these divalent carboxylic acids can be used alone, or two or more thereof can be used in combination as appropriate.
これらの二価カルボン酸のうち、油剤として軽い感触の使用感が得られる観点から、炭
素数14以上22以下の直鎖又は分岐鎖の二価カルボン酸が好ましく、炭素数14以上20以下の直鎖の二価カルボン酸がより好ましい。具体的には、前記の観点から、テトラデカン二酸、ペンタデカン二酸、ヘキサデカン二酸、オクタデカン二酸、8−エチルオクタデカン二酸、エイコサン二酸及びジメチルエイコサン二酸から選択される1種又は2種以上が好ましく、テトラデカン二酸及びエイコサン二酸から選択される1種又は2種がより好ましい。
Among these divalent carboxylic acids, straight-chain or branched divalent carboxylic acids having 14 or more and 22 or less carbon atoms are preferable, and direct or 20 or less carbon atoms are preferable from the viewpoint of obtaining a light feel as an oil agent. A chain divalent carboxylic acid is more preferred. Specifically, from the above viewpoint, one or 2 selected from tetradecane diic acid, pentadecane diic acid, hexadecane diic acid, octadecane diic acid, 8-ethyl octadecane diic acid, eicosan diic acid and dimethyl eicosan diic acid. More than one kind is preferable, and one or two kinds selected from tetradecanedioic acid and eicosandioic acid are more preferable.
また、二価カルボン酸とエステル体を形成するポリグリセリンとしては、水酸基価から
算出した平均重合度2以上15以下のポリグリセリンが用いられる。ポリグリセリンの平均重合度は、水性成分との溶解性の良さの点から、好ましくは8以上、より好ましくは9以上であり、また、好ましくは15以下、より好ましくは12以下である。中でも、平均重合度10のポリグリセリンを含むものが好ましい。
Further, as the polyglycerin forming an ester with the divalent carboxylic acid, a polyglycerin having an average degree of polymerization of 2 or more and 15 or less calculated from the hydroxyl value is used. The average degree of polymerization of polyglycerin is preferably 8 or more, more preferably 9 or more, and preferably 15 or less, more preferably 12 or less, from the viewpoint of good solubility in an aqueous component. Among them, those containing polyglycerin having an average degree of polymerization of 10 are preferable.
二価カルボン酸とポリグリセリンとのオリゴマーエステルの製造方法は、特開2007−137847号公報に記載の方法が挙げられる。本発明のオリゴマーエステルの重合度は、二価カルボン酸とポリグリセリンの仕込み比により調整することができる。オリゴマーエステルの粘度が高すぎず、べたつきを抑制する観点から、ポリグリセリン1モル当量に対する二価カルボン酸の量は、好ましくは0.3モル当量以上、より好ましくは0.7モル当量以上であり、また、好ましくは1.5モル当量以下、より好ましくは1.2モル当量以下である。 Examples of the method for producing an oligomer ester of a divalent carboxylic acid and polyglycerin include the methods described in JP-A-2007-137847. The degree of polymerization of the oligomer ester of the present invention can be adjusted by the charging ratio of divalent carboxylic acid and polyglycerin. From the viewpoint that the viscosity of the oligomer ester is not too high and stickiness is suppressed, the amount of divalent carboxylic acid with respect to 1 molar equivalent of polyglycerin is preferably 0.3 molar equivalent or more, more preferably 0.7 molar equivalent or more. Also, it is preferably 1.5 molar equivalents or less, more preferably 1.2 molar equivalents or less.
これらオリゴマーエステルの好適な例としては、テトラデカン二酸及び/又はエイコサン二酸と、平均重合度10のポリグリセリンとから構成されるオリゴマーエステルである、(エイコサン二酸/テトラデカン二酸)ポリグリセリル−10が挙げられる。このオリゴマーエステルは、Neosolue(登録商標)−Aqua、Neosolue(登録商標)−AquaS(いずれも日本精化株式会社)として市販されているものである。 A preferred example of these oligomeric esters is (eicosane diic acid / tetradecanedic acid) polyglyceryl-10, which is an oligomeric ester composed of tetradecanedioic acid and / or icosane diic acid and polyglycerin having an average degree of polymerization of 10. Can be mentioned. This oligomer ester is commercially available as Neosolue (registered trademark) -Aqua and Neosolue (registered trademark) -AquaS (both are Nippon Fine Chemical Co., Ltd.).
本発明の皮膚外用剤にオリゴマーエステルを配合する場合の配合量は、0.008質量%以上であって、0.02質量%以上が更に好ましい。また、高温及び低温安定性、肌馴染みの良さを向上させる観点から、6質量%以下であって、4質量%以下が好ましい。具体的には、0.008〜6質量%であって、0.02〜4質量%がより好ましい。 When the oligomer ester is blended with the external preparation for skin of the present invention, the blending amount is 0.008% by mass or more, more preferably 0.02% by mass or more. Further, from the viewpoint of improving high-temperature and low-temperature stability and good skin compatibility, it is preferably 6% by mass or less, preferably 4% by mass or less. Specifically, it is 0.008 to 6% by mass, more preferably 0.02 to 4% by mass.
ホスホリルコリン基含有重合体(以下、PC重合体と略記することもある。)は、ホスホリルコリン基含有単量体(以下、PC単量体と略記することもある。)、好ましくは式(1)で表される2−メタクリロイルオキシエチルホスホリルコリン(以下、MPC単量体と略記することもある。)を含む単量体組成物を、ラジカル重合してなる重合体(以下、MPC重合体と略記することもある。)等が挙げられる。MPC重合体は、反応性基及びフルオロアルキル基を含まない重合体であることが好ましい。 The phosphorylcholine group-containing polymer (hereinafter, may be abbreviated as PC polymer) is a phosphorylcholine group-containing monomer (hereinafter, may be abbreviated as PC monomer), preferably in the formula (1). A polymer obtained by radically polymerizing a monomer composition containing 2-methacryloyloxyethyl phosphorylcholine (hereinafter, may be abbreviated as MPC monomer) represented (hereinafter, abbreviated as MPC polymer). There is also.) Etc. The MPC polymer is preferably a polymer that does not contain a reactive group and a fluoroalkyl group.
PC重合体を合成するための単量体組成物としては、例えば、上記PC単量体、特にMPC単量体単独、もしくはPC単量体、特にMPC単量体と、該PC単量体と共重合可能な、反応性基及びフルオロアルキル基を含まないラジカル重合性単量体との混合物が挙げられる。 Examples of the monomer composition for synthesizing the PC polymer include the above-mentioned PC monomer, particularly MPC monomer alone, or a PC monomer, particularly MPC monomer, and the PC monomer. Examples thereof include a mixture with a radically polymerizable monomer which is copolymerizable and does not contain a reactive group and a fluoroalkyl group.
前記ラジカル重合性単量体としては、例えば、(メタ)アクリル酸及びその塩類、ヒドロキシエチル(メタ)アクリレート、ヒドロキシプロピル(メタ)アクリレート、グリセロール(メタ)アクリレート、N−イソプロピル(メタ)アクリルアミド、メチル(メタ)アクリレート、エチル(メタ)アクリレート、ブチル(メタ)アクリレート、ラウリル(メタ)アクリレート、ステアリル(メタ)アクリレート、2−エチルヘキシル(メタ)アクリレート、ベンジル(メタ)アクリレート、フェノキシエチル(メタ)アクリレート、シクロヘキシル(メタ)アクリレート、ポリプロピレングリコールモノ(メタ)アクリレート、ポリテトラメチレングリコールモノ(メタ)アクリレート、ポリプロピレングリコールジ(メタ)アクリレート、ポリテトラメチレングリコールジ(メタ)アクリレート、ポリプロピレングリコールポリエチレングリコールモノ(メタ)アクリレート等が挙げられる。これらの単量体のうち、ヒドロキシエチル(メタ)アクリレート、ブチル(メタ)アクリレート、ラウリル(メタ)アクリレート、ステアリル(メタ)アクリレートが、入手性及び単量体の生物学的安全性の点からより好ましい。これらの単量体は、MPC重合体の製造にあたって単独でも2種以上の混合物としても用いることができる。 Examples of the radically polymerizable monomer include (meth) acrylic acid and salts thereof, hydroxyethyl (meth) acrylate, hydroxypropyl (meth) acrylate, glycerol (meth) acrylate, N-isopropyl (meth) acrylamide, and methyl. (Meta) acrylate, ethyl (meth) acrylate, butyl (meth) acrylate, lauryl (meth) acrylate, stearyl (meth) acrylate, 2-ethylhexyl (meth) acrylate, benzyl (meth) acrylate, phenoxyethyl (meth) acrylate, Cyclohexyl (meth) acrylate, polypropylene glycol mono (meth) acrylate, polytetramethylene glycol mono (meth) acrylate, polypropylene glycol di (meth) acrylate, polytetramethylene glycol di (meth) acrylate, polypropylene glycol polyethylene glycol mono (meth) Examples include acrylate. Of these monomers, hydroxyethyl (meth) acrylate, butyl (meth) acrylate, lauryl (meth) acrylate, and stearyl (meth) acrylate are more available in terms of availability and biological safety of the monomer. preferable. These monomers can be used alone or as a mixture of two or more kinds in the production of the MPC polymer.
前記PC重合体、特に、MPC重合体としては、PC単量体、特にMPC単量体を含む単量体組成物を、溶液重合、乳化重合、懸濁重合等、公知の方法に従って重合することによって得ることができる。例えば、溶液重合の場合、単量体組成物を低級アルコール等の有機溶媒中に溶解し、窒素、アルゴン等不活性ガスの雰囲気下、アゾ化合物や過酸化物等のラジカル重合開始剤を添加して加熱、攪拌することにより得ることができる。また、MPC重合体は市販品を用いることもできる。Lipidure(登録商標)(日油株式会社)等が挙げられる。MPC重合体を含むMPC重合体の形態としては、粉状、溶液状又は均一分散液体状のいずれでもよい。 As the PC polymer, particularly the MPC polymer, a PC monomer, particularly a monomer composition containing the MPC monomer, is polymerized according to a known method such as solution polymerization, emulsion polymerization, suspension polymerization or the like. Can be obtained by For example, in the case of solution polymerization, the monomer composition is dissolved in an organic solvent such as a lower alcohol, and a radical polymerization initiator such as an azo compound or a peroxide is added in an atmosphere of an inert gas such as nitrogen or argon. It can be obtained by heating and stirring. In addition, a commercially available product can also be used as the MPC polymer. Lipidure (registered trademark) (NOF CORPORATION) and the like can be mentioned. The form of the MPC polymer containing the MPC polymer may be powdery, solution or uniformly dispersed liquid.
前記PC重合体は、好ましくはMPC単量体に由来する共重合組成比が10〜100モル%の範囲のMPC重合体を適宜選定することができるが、MPC単量体に由来する共重合組成比が30〜100モル%の範囲がより好ましい。 As the PC polymer, an MPC polymer having a copolymerization composition ratio derived from the MPC monomer in the range of 10 to 100 mol% can be appropriately selected, but the copolymer composition derived from the MPC monomer can be appropriately selected. More preferably, the ratio is in the range of 30-100 mol%.
前記MPC重合体を含む前記PC重合体の重量平均分子量は、10000〜10000000の範囲が好ましく、50000〜3000000の範囲がより好ましい。 The weight average molecular weight of the PC polymer containing the MPC polymer is preferably in the range of 10,000,000 to 10000000, more preferably in the range of 50,000 to 3000000.
本発明の皮膚外用剤において、MPC重合体を含むPC重合体を配合する場合の配合量は、0.001〜5質量%が好ましく、0.001〜4質量%がより好ましい。 In the external preparation for skin of the present invention, when the PC polymer containing the MPC polymer is blended, the blending amount is preferably 0.001 to 5% by mass, more preferably 0.001 to 4% by mass.
トリメチルグリシンは、特に限定されず市販品を用いることができる。市販品としては、GENENCARE(登録商標) OSMS BA(Finnfeeds Finland Ltd)、アクアデュウ(登録商標) AN−100(味の素株式会社)、アミノコート(登録商標)(旭化成ファインケム株式会社)等が挙げられる。 The trimethylglycine is not particularly limited, and a commercially available product can be used. Examples of commercially available products include GENENCARE (registered trademark) OSMS BA (Finneds Finland Ltd), Aquadu (registered trademark) AN-100 (Ajinomoto Co., Inc.), Aminocoat (registered trademark) (Asahi Kasei Finechem Co., Ltd.) and the like.
本発明の皮膚外用剤へのトリメチルグリシンの配合量は、特に限定されないが、種類や目的等によって調整することができる。トリメチルグリシンを配合する場合、効果や安定性等の点から、皮膚外用剤全量に対して、好ましくは0.01〜20質量%であり、より好ましくは0.1〜20質量%であり、さらに好ましくは0.1〜10質量%である。 The amount of trimethylglycine blended in the external preparation for skin of the present invention is not particularly limited, but can be adjusted depending on the type, purpose, and the like. When trimethylglycine is blended, it is preferably 0.01 to 20% by mass, more preferably 0.1 to 20% by mass, and further, with respect to the total amount of the external preparation for skin, from the viewpoint of effect and stability. It is preferably 0.1 to 10% by mass.
アルキレンオキシド誘導体は、下記式(2):
Z−{O(AO)l(EO)m−(BO)nH}a …式(2)
(式中、
Zは3〜9個の水酸基を有する化合物の水酸基を除いた残基を表し;
AOは炭素数3〜4のオキシアルキレン基を表し;
EOはオキシエチレン基を表し;BOは炭素数4のオキシアルキレン基を表し;
aは3〜9を表し;
l、m及びnは、それぞれ、AO、EO及びBOの平均付加モル数であって、1≦l≦50、1≦m≦50及び0.5≦n≦5であり;
AOとEOとの重量比(AO/EO)は1/5〜5/1であり;
AO及びEOはランダム状又はブロック状に付加されてもよい。)
で表される。上記のアルキレンオキシド誘導体は単一種類であってもよく、若しくは、複数種類の混合物であってもよい。
The alkylene oxide derivative has the following formula (2):
Z- {O (AO) l (EO) m- (BO) nH} a ... Equation (2)
(During the ceremony,
Z represents the residue of the compound having 3 to 9 hydroxyl groups excluding the hydroxyl group;
AO represents an oxyalkylene group having 3 to 4 carbon atoms;
EO represents an oxyethylene group; BO represents an oxyalkylene group having 4 carbon atoms;
a represents 3-9;
l, m and n are the average number of moles of AO, EO and BO, respectively, 1 ≦ l ≦ 50, 1 ≦ m ≦ 50 and 0.5 ≦ n ≦ 5.
The weight ratio of AO to EO (AO / EO) is 1/5 to 5/1;
AO and EO may be added randomly or in blocks. )
It is represented by. The above-mentioned alkylene oxide derivative may be a single type or a mixture of a plurality of types.
式(2)で示されるアルキレンオキシド誘導体において、Zは3〜9個の水酸基を有する化合物の水酸基を除いた残基であり、aはZの化合物の水酸基の数であり3〜9である。3〜9個の水酸基を有する化合物として、例えば、a=3であればグリセリン、トリメチロールプロパン、a=4であれば、エリスリトール、ペンタエリスリトール、ソルビタン、アルキルグリコシド、ジグリセリン、a=5であればキシリトール、a=6であればジペンタエリスリトール、ソルビトール、イノシトール、a=8であればショ糖、トレハロース、a=9であればマルチトール、及び、これらの混合物等が挙げられる。好ましくは、Zは3〜6個の水酸基を有する化合物の水酸基を除いた残基であり、3≦a≦6を満たす。3〜9個の水酸基を有する化合物としてはグリセリン、トリメチロールプロパンが好ましく、グリセリンが特に好ましい。なお、a≦2では、油脂などの油性成分との相溶性に劣り油性製剤への配合安定性が悪化する傾向がある。10≦aではべたつき感が生じる。 In the alkylene oxide derivative represented by the formula (2), Z is a residue excluding the hydroxyl group of the compound having 3 to 9 hydroxyl groups, and a is the number of hydroxyl groups of the compound of Z and is 3 to 9. Compounds having 3 to 9 hydroxyl groups include, for example, glycerin and trimethylolpropane when a = 3, erythritol, pentaerythritol, sorbitol, alkylglycoside, diglycerin and a = 5 when a = 4. Examples thereof include xylitol, dipentaerythritol, sorbitol and inositol when a = 6, sucrose and trehalose when a = 8, maltitol when a = 9, and mixtures thereof. Preferably, Z is a residue of the compound having 3 to 6 hydroxyl groups excluding the hydroxyl group, and satisfies 3 ≦ a ≦ 6. As the compound having 3 to 9 hydroxyl groups, glycerin and trimethylolpropane are preferable, and glycerin is particularly preferable. When a ≦ 2, the compatibility with oily components such as fats and oils is inferior, and the compounding stability in the oily preparation tends to deteriorate. When 10 ≦ a, a sticky feeling occurs.
AOは炭素数3〜4のオキシアルキレン基であり、例として、オキシプロピレン基、オキシブチレン基(オキシn−ブチレン基、オキシイソブチレン基、オキシt−ブチレン基)、オキシトリメチレン基、オキシテトラメチレン基等が挙げられる。好ましくは、オキシプロピレン基、オキシブチレン基、さらに好ましくはオキシプロピレン基である。 AO is an oxyalkylene group having 3 to 4 carbon atoms, and examples thereof include an oxypropylene group, an oxybutylene group (oxyn-butylene group, an oxyisobutylene group, an oxyt-butylene group), an oxytrimethylene group, and an oxytetramethylene group. The group etc. can be mentioned. It is preferably an oxypropylene group, an oxybutylene group, and more preferably an oxypropylene group.
lはAOの平均付加モル数であり、1≦l≦50、好ましくは2≦l≦20である。mはEOの平均付加モル数であり、1≦m≦50、好ましくは2≦m≦20である。lが0であるとべたつき感を生じてしまい、50を超えると保湿効果が低下してしまうので好ましくない。また、mが0であると保湿効果が低下してしまい、50を超えるとべたつき感が生じてしまうので好ましくない。 l is the average number of moles added of AO, which is 1 ≦ l ≦ 50, preferably 2 ≦ l ≦ 20. m is the average number of moles added of EO, which is 1 ≦ m ≦ 50, preferably 2 ≦ m ≦ 20. If l is 0, a sticky feeling is generated, and if it exceeds 50, the moisturizing effect is lowered, which is not preferable. Further, if m is 0, the moisturizing effect is lowered, and if it exceeds 50, a sticky feeling is generated, which is not preferable.
AOとEOとの重量比(AO/EO)は1/5〜5/1であり、好ましくは1/4〜4/1である。1/5より小さいとべたつき感を生じてしまい、5/1より大きいと保湿感が低下してしまうので好ましくない。AOとEOの付加する順序は特に指定はなく、ブロック状に付加していてもランダム状に付加していてもよい。好ましくはランダム状に付加されているものである。 The weight ratio of AO to EO (AO / EO) is 1/5 to 5/1, preferably 1/4 to 4/1. If it is less than 1/5, a sticky feeling is generated, and if it is larger than 5/1, the moisturizing feeling is lowered, which is not preferable. The order in which AO and EO are added is not particularly specified, and may be added in a block shape or randomly. It is preferably added randomly.
BOは炭素数4のオキシアルキレン基であり、例としてはオキシブチレン基(オキシn−ブチレン基、オキシイソブチレン基、オキシt−ブチレン基)、オキシテトラメチレン基等が挙げられる。好ましくはオキシブチレン基である。 BO is an oxyalkylene group having 4 carbon atoms, and examples thereof include an oxybutylene group (oxyn-butylene group, an oxyisobutylene group, an oxyt-butylene group), an oxytetramethylene group and the like. It is preferably an oxybutylene group.
nはBOの平均付加モル数であり、0.5<n≦5であり、好ましくは0.8≦n≦3であり、より好ましくは1≦n≦3である。0.5以下であるとべたつき感が生じてしまい、5を超えると保湿感が低下してしまうので好ましくない。なお、式(2)において、(BO)nは末端水素原子に結合していることが必要である。 n is the average number of moles added of BO, 0.5 <n ≦ 5, preferably 0.8 ≦ n ≦ 3, and more preferably 1 ≦ n ≦ 3. If it is 0.5 or less, a sticky feeling is generated, and if it exceeds 5, the moisturizing feeling is lowered, which is not preferable. In the formula (2), (BO) n needs to be bonded to the terminal hydrogen atom.
式(2)で示されるアルキレンオキシド誘導体は、公知の方法で製造することができる。例えば、3〜9個の水酸基を有している化合物にエチレンオキシドおよび炭素数3〜4のアルキレンオキシドを付加重合した後に、炭素数4のアルキレンオキシドを反応させることによって得られる。なお、3〜9個の水酸基を有している化合物にエチレンオキシドおよび炭素数3〜4のアルキレンオキシドを付加重合する段階においては、エチレンオキシドとアルキレンオキシドとをランダム重合してもよく、又は、ブロック重合してもよい。 The alkylene oxide derivative represented by the formula (2) can be produced by a known method. For example, it is obtained by addition-polymerizing ethylene oxide and an alkylene oxide having 3 to 4 carbon atoms to a compound having 3 to 9 hydroxyl groups, and then reacting the alkylene oxide having 4 carbon atoms. At the stage of addition polymerization of ethylene oxide and alkylene oxide having 3 to 4 carbon atoms to a compound having 3 to 9 hydroxyl groups, ethylene oxide and alkylene oxide may be randomly polymerized or block polymerization. You may.
式(2)で示されるアルキレンオキシド誘導体のうち、好ましい前記アルキレンオキシド誘導体としては、例えば、下記式(2−1):
Gly−[O(PO)s(EO)t−(BO)uH]3 …式(2−1)
(式中、
Glyはグリセリンから水酸基を除いた残基を表し;
POはオキシプロピレン基を表し;
EOはオキシエチレン基を表し;
sおよびtはそれぞれPOおよびEOの平均付加モル数であって、1〜50の値であり、
POとEOとの質量比(PO/EO)は1/5〜5/1であって、
BOは炭素数4のオキシアルキレン基を表し;
uはBOの平均付加モル数であって、0.5〜5の値である。)
のアルキレンオキシド誘導体(ポリオキシブチレンポリオキシエチレンポリオキシプロピレングリセロール)が挙げられる。
Among the alkylene oxide derivatives represented by the formula (2), the preferred alkylene oxide derivative is, for example, the following formula (2-1):
Gly- [O (PO) s (EO) t- (BO) uH] 3 ... Equation (2-1)
(During the ceremony,
Gly represents the residue obtained by removing the hydroxyl group from glycerin;
PO represents an oxypropylene group;
EO represents an oxyethylene group;
s and t are the average number of moles added of PO and EO, respectively, and are values of 1 to 50.
The mass ratio of PO and EO (PO / EO) is 1/5 to 5/1.
BO represents an oxyalkylene group having 4 carbon atoms;
u is the average number of moles added of BO, which is a value of 0.5 to 5. )
Alkylene oxide derivative (polyoxybutylene polyoxyethylene polyoxypropylene glycerol) can be mentioned.
式(2−1)のアルキレンオキシド誘導体は、グリセリンにプロピレンオキシドおよびエチレンオキシドをそれぞれグリセリンに対して3〜150モル当量の割合で付加させた後に、炭素数4のアルキレンオキシドをグリセリンに対して1.5〜15モル当量の割合で付加させて得られる。 The alkylene oxide derivative of the formula (2-1) is obtained by adding propylene oxide and ethylene oxide to glycerin at a ratio of 3 to 150 molar equivalents with respect to glycerin, and then adding an alkylene oxide having 4 carbon atoms to glycerin. It is obtained by addition at a ratio of 5 to 15 molar equivalents.
グリセリンにこれらのアルキレンオキシドを付加させる場合、アルカリ触媒、相関移動触媒、ルイス酸触媒などを用いて付加反応を行う。一般的には、水酸化カリウムなどのアルカリ触媒を用いることが好ましい。 When these alkylene oxides are added to glycerin, the addition reaction is carried out using an alkali catalyst, a phase transfer catalyst, a Lewis acid catalyst, or the like. Generally, it is preferable to use an alkaline catalyst such as potassium hydroxide.
式(2)で示されるアルキレンオキシド誘導体のうち、更に好ましいものは、グリセリンに6〜10モルのエチレンオキシド及び3〜7モルのプロピレンオキシドを付加させた後に、2〜4モルのブチレンオキシドを付加させたものである。 Of the alkylene oxide derivatives represented by the formula (2), more preferable ones are added with 6 to 10 mol of ethylene oxide and 3 to 7 mol of propylene oxide to glycerin, followed by addition of 2 to 4 mol of butylene oxide. It is a thing.
式(2)で示されるアルキレンオキシド誘導体のうち、更により好ましいものは、グリセリンに8モルのエチレンオキシド及び5モルのプロピレンオキシドを付加させた後に、3モルのブチレンオキシドを付加させた、ポリオキシブチレンポリオキシエチレンポリオキシプロピレングリセロールであり、PEG/PPG/ポリブチレングリコール−8/5/3グリセリンと称される。このアルキレンオキシド誘導体は、WILBRIDE(登録商標) S−753、WILBRIDE(登録商標) S−753D(いずれも日油株式会社)として市販されているものである。 Of the alkylene oxide derivatives represented by the formula (2), even more preferable is polyoxybutylene obtained by adding 8 mol of ethylene oxide and 5 mol of propylene oxide to glycerin and then adding 3 mol of butylene oxide. It is polyoxyethylene polyoxypropylene glycerol and is referred to as PEG / PPG / polybutylene glycol-8 / 5/3 glycerin. This alkylene oxide derivative is commercially available as WILBRIDE (registered trademark) S-753 and WILBRIDE (registered trademark) S-753D (both are NOF CORPORATION).
本発明の皮膚外用剤へのアルキレンオキシド誘導体の配合量は、特に限定されず、種類や目的等によって調整することができる。アルキレンオキシド誘導体を配合する場合、効果や安定性等の点から皮膚外用剤全量に対して、0.01質量%以上が好ましく、また、20質量%以下が好ましく、より好ましくは10質量%以下である。具体的には、好ましくは0.01〜20質量%であり、より好ましくは0.01〜10質量%であり、さらに好ましくは0.1〜10質量%である。20質量%を超えて配合すると、使用感上べたつきが問題となる場合がある。 The blending amount of the alkylene oxide derivative in the external preparation for skin of the present invention is not particularly limited and can be adjusted depending on the type, purpose and the like. When the alkylene oxide derivative is blended, it is preferably 0.01% by mass or more, preferably 20% by mass or less, and more preferably 10% by mass or less with respect to the total amount of the external preparation for skin from the viewpoint of effect and stability. be. Specifically, it is preferably 0.01 to 20% by mass, more preferably 0.01 to 10% by mass, and further preferably 0.1 to 10% by mass. If it is blended in excess of 20% by mass, stickiness may become a problem in terms of usability.
本発明の皮膚外用剤には上述の必須成分の他に、必要に応じて通常皮膚外用剤に配合される、水性成分、油性成分、保湿剤、色素、界面活性剤、紫外線吸収剤、増粘剤、美容成分、香料、高分子物質、防菌防黴剤、アルコール類、粉体、スクラブ剤、生体由来成分等を適宜配合することができる。 In addition to the above-mentioned essential components, the skin external preparation of the present invention usually contains an aqueous component, an oily component, a moisturizer, a pigment, a surfactant, an ultraviolet absorber, and a thickening agent, which are usually added to the skin external preparation as needed. Agents, beauty ingredients, fragrances, polymer substances, antibacterial and antifungal agents, alcohols, powders, scrubbing agents, biological ingredients and the like can be appropriately blended.
本発明の皮膚外用剤は、例えば、ローション剤、乳剤、軟膏の剤型で用いることができる。また、本発明の皮膚外用剤は、製造方法を問わない。 The external preparation for skin of the present invention can be used in, for example, lotions, emulsions, and ointments. In addition, the external preparation for skin of the present invention may be produced regardless of the production method.
以下、実施例により本発明を具体的に説明するが、これにより本発明の範囲が限定されるものではない。なお、配合量は特に断りのない限り質量%である。 Hereinafter, the present invention will be specifically described with reference to Examples, but the scope of the present invention is not limited thereto. The blending amount is mass% unless otherwise specified.
[保湿効果試験方法]
表1及び表2に示した試料を調製し、皮表角層水分量の測定を行った。
[Moisturizing effect test method]
The samples shown in Tables 1 and 2 were prepared, and the water content of the skin surface stratum corneum was measured.
[測定方法]
(1)馴化
被験者は左右前腕内側部を洗浄後、水分をふき取り、温度21±0.5℃、湿度50±5%に調整された室内で15分間安静にし、馴化を行った。
(2)塗布
左右前腕内側部に3cm×3cmの領域を記し、ピペットを用いて9μLを滴下し、指サックをした指で均一に塗布した。
(3)測定
塗布前及び塗布後60分後の皮表角層水分量をSKICON−200EXを用いて測定した。皮表角層水分量は塗布前の水分量を100とした場合の相対値を算出し、表1及び表2に示した。皮表角層水分量は、測定当日の気温、湿度等の影響を受けやすいため、一群の試料は同日に評価し、塗布前の測定も試料を塗布した部位での測定値を相対値の基準とした。
[Measuring method]
(1) Acclimation The subject washed the medial parts of the left and right forearms, wiped off the water, and rested for 15 minutes in a room adjusted to a temperature of 21 ± 0.5 ° C. and a humidity of 50 ± 5% for acclimatization.
(2) Application A 3 cm × 3 cm area was marked on the medial side of the left and right forearms, 9 μL was dropped using a pipette, and the area was evenly applied with a finger cot.
(3) Measurement The water content of the surface stratum corneum before application and 60 minutes after application was measured using SKICON-200EX. The skin surface stratum corneum water content was calculated as a relative value when the water content before application was 100, and is shown in Tables 1 and 2. Since the water content of the skin surface stratum corneum is easily affected by the temperature, humidity, etc. on the day of measurement, a group of samples are evaluated on the same day, and the measurement before application is also based on the measured value at the site where the sample is applied as a relative value. And said.
[保湿効果試験方法]
表3及び表4に示した試料を調製し、経表皮水分蒸散量の測定を行った。
[Moisturizing effect test method]
The samples shown in Tables 3 and 4 were prepared, and the transepidermal water loss was measured.
[測定方法]
(1)馴化
被験者は左右前腕内側部を洗浄後、水分をふき取り、温度20±0.5℃、湿度50±5%に調整された室内で15分間安静にし、馴化を行った。
(2)塗布
左右前腕内側部に3cm×3cmの領域を記し、ピペットを用いて9μLを滴下し、指サックをした指で均一に塗布した。
(3)測定
塗布前及び塗布後60分後の経表皮水分蒸散量をVapometerを用いて測定した。経表皮水分蒸散量は塗布前の経表皮水分蒸散量を100とした場合の相対値を算出し、表3及び表4に示した。経表皮水分蒸散量は、測定当日の気温、湿度等の影響を受けやすいため、一群の試料は同日に評価し、塗布前の測定も試料を塗布した部位での測定値を相対値の基準とした。
[Measuring method]
(1) Acclimation The subject washed the medial parts of the left and right forearms, wiped off the water, and rested for 15 minutes in a room adjusted to a temperature of 20 ± 0.5 ° C. and a humidity of 50 ± 5% for acclimatization.
(2) Application A 3 cm × 3 cm area was marked on the medial side of the left and right forearms, 9 μL was dropped using a pipette, and the area was evenly applied with a finger cot.
(3) Measurement The amount of transepidermal water loss before application and 60 minutes after application was measured using Vapometer. The transepidermal moisture evaporation amount was calculated as a relative value when the transepidermal moisture evaporation amount before application was set to 100, and is shown in Tables 3 and 4. Since the amount of transepidermal water loss is easily affected by the temperature, humidity, etc. on the day of measurement, a group of samples should be evaluated on the same day, and the measurement before application should be based on the measured value at the site where the sample was applied. bottom.
表1に示した通り、実施例1は、グリセリルグルコシドを実施例1と比較して倍量含有する比較例1及び、(エイコサン二酸/テトラデカン二酸)ポリグリセリル−10を実施例1と比較して倍量含有する比較例2、と比較して皮表角層水分量が相乗的に向上していた。 As shown in Table 1, Example 1 compared Comparative Example 1 containing twice the amount of glyceryl glucoside with Example 1 and Polyglyceryl-10 (eicosanedioic acid / tetradecanedioic acid) with Example 1. Compared with Comparative Example 2 containing a double amount of water, the water content of the surface stratum corneum was synergistically improved.
表2に示した通り、実施例2は、グリセリルグルコシドを実施例2と比較して倍量含有する比較例1及び、2−メタクリロイルオキシエチルホスホリルコリン・メタクリル酸ブチル共重合体液を実施例2と比較して倍量含有する比較例3、と比較して皮表角層水分量が相乗的に向上していた。 As shown in Table 2, in Example 2, Comparative Example 1 containing twice the amount of glyceryl glucoside as compared with Example 2 and 2-methacryloyloxyethyl phosphorylcholine / butyl methacrylate copolymer solution were compared with Example 2. As a result, the water content of the surface stratum corneum was synergistically improved as compared with Comparative Example 3 in which the content was doubled.
表3に示した通り、実施例3は、グリセリルグルコシドを実施例3と比較して倍量含有する比較例4及び、トリメチルグリシンを実施例3と比較して倍量含有する比較例5、と比較して経表皮水分蒸散量が相乗的に低下していた。 As shown in Table 3, Example 3 includes Comparative Example 4 containing a double amount of glyceryl glucoside as compared with Example 3, and Comparative Example 5 containing a double amount of trimethylglycine as compared with Example 3. In comparison, the transepidermal water loss was synergistically reduced.
表4に示した通り、実施例4は、グリセリルグルコシドを実施例4と比較して倍量含有する比較例4及び、PEG/PPG/ポリブチレングリコール−8/5/3グリセリンを実施例4と比較して倍量含有する比較例6、と比較して経表皮水分蒸散量が相乗的に低下していた。 As shown in Table 4, Example 4 contains glyceryl glucoside in a double amount as compared with Example 4, and PEG / PPG / polybutylene glycol-8 / 5/3 glycerin as compared with Example 4. Compared with Comparative Example 6 in which the content was doubled, the transepidermal water loss amount was synergistically reduced.
[実施例5]クリーム
(1)スクワラン 10.0(質量%)
(2)ステアリン酸 2.0
(3)水素添加パーム核油 0.5
(4)水素添加大豆リン脂質 0.1
(5)セタノール 3.6
(6)親油型モノステアリン酸グリセリン 2.0
(7)グリセリン 10.0
(8)パラオキシ安息香酸メチル 0.1
(9)アルギニン(20質量%水溶液) 15.0
(10)精製水 全量を100とする量
(11)カルボキシビニルポリマー(1質量%水溶液) 15.0
(12)トラネキサム酸 2.0
(13)グリセリルグルコシド(注1) 0.5
(14)(エイコサン二酸/テトラデカン二酸)
ポリグリセリル−10(注2) 0.5
[Example 5] Cream (1) Squalene 10.0 (mass%)
(2) Stearic acid 2.0
(3) Hydrogenated palm kernel oil 0.5
(4) Hydrogenated soybean phospholipid 0.1
(5) Cetanol 3.6
(6) Polyoil-type glycerin monostearate 2.0
(7) Glycerin 10.0
(8) Methyl paraoxybenzoate 0.1
(9) Arginine (20% by mass aqueous solution) 15.0
(10) Amount of purified water totaling 100 (11) Carboxyvinyl polymer (1% by mass aqueous solution) 15.0
(12) Tranexamic acid 2.0
(13) Glyceryl glucoside (Note 1) 0.5
(14) (Icosanedioic acid / tetradecanedioic acid)
Polyglyceryl-10 (Note 2) 0.5
[実施例6]乳液
(1)スクワラン 10.0(質量%)
(2)メチルフェニルポリシロキサン 4.0
(3)水素添加パーム核油 0.5
(4)水素添加大豆リン脂質 0.1
(5)モノステアリン酸ポリオキシエチレン
ソルビタン(20E.O.) 1.3
(6)モノステアリン酸ソルビタン 1.0
(7)グリセリン 4.0
(8)パラオキシ安息香酸メチル 0.1
(9)カルボキシビニルポリマー 0.15
(10)精製水 全量を100とする量
(11)アルギニン(1質量%水溶液) 20.0
(12)トラネキサム酸 1.0
(13)グリセリルグルコシド(注1) 0.5
(14)2−メタクリロイルオキシエチルホスホリルコリン
・メタクリル酸ブチル共重合体液(注3) 0.3
[Example 6] Emulsion (1) Squalene 10.0 (mass%)
(2) Methylphenylpolysiloxane 4.0
(3) Hydrogenated palm kernel oil 0.5
(4) Hydrogenated soybean phospholipid 0.1
(5) Polyoxyethylene monostearate
Sorbitan (20EO) 1.3
(6) Sorbitan monostearate 1.0
(7) Glycerin 4.0
(8) Methyl paraoxybenzoate 0.1
(9) Carboxyvinyl polymer 0.15
(10) Amount of purified water with 100 as a whole (11) Arginine (1% by mass aqueous solution) 20.0
(12) Tranexamic acid 1.0
(13) Glyceryl glucoside (Note 1) 0.5
(14) 2-methacryloyloxyethyl phosphorylcholine / butyl methacrylate copolymer solution (Note 3) 0.3
[実施例7]化粧水
(1)エタノール 15.0(質量%)
(2)ポリオキシエチレン(40E.O.)硬化ヒマシ油 0.3
(3)香料 0.1
(4)精製水 全量を100とする量
(5)クエン酸 0.02
(6)クエン酸ナトリウム 0.1
(7)グリセリン 1.0
(8)ヒドロキシエチルセルロース 0.1
(9)トラネキサム酸 2.0
(10)グリセリルグルコシド(注1) 0.3
(11)PEG/PPG/ポリブチレングリコール
−8/5/3グリセリン(注5) 0.5
[Example 7] Toner (1) Ethanol 15.0 (mass%)
(2) Polyoxyethylene (40EO) hardened castor oil 0.3
(3) Fragrance 0.1
(4) Amount of purified water with 100 as a whole (5) Citric acid 0.02
(6) Sodium citrate 0.1
(7) Glycerin 1.0
(8) Hydroxyethyl cellulose 0.1
(9) Tranexamic acid 2.0
(10) Glyceryl glucoside (Note 1) 0.3
(11) PEG / PPG / polybutylene glycol-8 / 5/3 glycerin (Note 5) 0.5
[実施例8]美容液
(1)精製水 全量を100とする量(質量%)
(2)グリセリン 10.0
(3)ショ糖脂肪酸エステル 1.3
(4)カルボキシビニルポリマー(1質量%水溶液) 17.5
(5)アルギン酸ナトリウム(1質量%水溶液) 15.0
(6)モノラウリン酸ポリグリセリル 1.0
(7)マカデミアナッツ油脂肪酸フィトステリル 3.0
(8)N−ラウロイル―L−グルタミン酸
ジ(フィトステリル−2−オクチルドデシル) 2.0
(9)硬化パーム油 2.0
(10)スクワラン(オリーブ由来) 1.0
(11)ベヘニルアルコール 0.75
(12)ミツロウ 1.0
(13)ホホバ油 1.0
(14)1,3−ブチレングリコール 10.0
(15)L−アルギニン(10質量%水溶液) 2.0
(16)トラネキサム酸 2.0
(17)グリセリルグルコシド(注1) 0.2
(18)(エイコサン二酸/テトラデカン二酸)
ポリグリセリル−10(注2) 0.2
(19)2−メタクリロイルオキシエチルホスホリルコリン
・メタクリル酸ブチル共重合体液(注3) 0.02
[Example 8] Beauty essence (1) Amount (mass%) with the total amount of purified water as 100
(2) Glycerin 10.0
(3) Sucrose fatty acid ester 1.3
(4) Carboxyvinyl polymer (1% by mass aqueous solution) 17.5
(5) Sodium alginate (1% by mass aqueous solution) 15.0
(6) Polyglyceryl monolaurate 1.0
(7) Macadamia nut oil fatty acid phytosteryl 3.0
(8) Di (phytosteryl-2-octyldodecyl) N-lauroyl-L-glutamic acid 2.0
(9) Hardened palm oil 2.0
(10) Squalene (derived from olives) 1.0
(11) Behenyl alcohol 0.75
(12) Beeswax 1.0
(13) Jojoba oil 1.0
(14) 1,3-butylene glycol 10.0
(15) L-arginine (10% by mass aqueous solution) 2.0
(16) Tranexamic acid 2.0
(17) Glyceryl glucoside (Note 1) 0.2
(18) (Icosanedioic acid / tetradecanedioic acid)
Polyglyceryl-10 (Note 2) 0.2
(19) 2-methacryloyloxyethyl phosphorylcholine / butyl methacrylate copolymer solution (Note 3) 0.02
[実施例9]水性ジェル
(1)カルボキシビニルポリマー 0.5(質量%)
(2)精製水 全量を100とする量
(3)水酸化ナトリウム(10質量%水溶液) 0.5
(4)パラオキシ安息香酸メチル 0.1
(5)トラネキサム酸 2.0
(6)グリセリルグルコシド(注1) 0.3
(7)トリメチルグリシン(注4) 0.2
(8)香料 0.1
(9)ポリオキシエチレン(60E.O.)硬化ヒマシ油 0.1
[Example 9] Aqueous gel (1) Carboxyvinyl polymer 0.5 (% by mass)
(2) Amount of purified water totaling 100 (3) Sodium hydroxide (10% by mass aqueous solution) 0.5
(4) Methyl paraoxybenzoate 0.1
(5) Tranexamic acid 2.0
(6) Glyceryl glucoside (Note 1) 0.3
(7) Trimethylglycine (Note 4) 0.2
(8) Fragrance 0.1
(9) Polyoxyethylene (60EO.) Hardened castor oil 0.1
[実施例10]クレンジング料
(1)スクワラン 81.0(質量%)
(2)イソステアリン酸ポリオキシエチレングリセリル 15.0
(3)精製水 全量を100とする量
(4)トラネキサム酸 1.0
(5)グリセリルグルコシド(注1) 0.2
(6)2−メタクリロイルオキシエチルホスホリルコリン
・メタクリル酸ブチル共重合体液(注3) 0.5
[Example 10] Cleansing agent (1) Squalene 81.0 (mass%)
(2) Polyoxyethylene glyceryl isostearate 15.0
(3) Amount of purified water with 100 as a whole (4) Tranexamic acid 1.0
(5) Glyceryl glucoside (Note 1) 0.2
(6) 2-methacryloyloxyethyl phosphorylcholine / butyl methacrylate copolymer solution (Note 3) 0.5
[実施例11]洗顔フォーム
(1)ステアリン酸 16.0(質量%)
(2)ミリスチン酸 16.0
(3)親油型モノステアリン酸グリセリン 2.0
(4)グリセリン 20.0
(5)水酸化ナトリウム 7.5
(6)ヤシ油脂肪酸アミドプロピルベタイン 1.0
(7)精製水 全量を100とする量
(8)トラネキサム酸 2.0
(9)グリセリルグルコシド(注1) 0.4
(10)(エイコサン二酸/テトラデカン二酸)
ポリグリセリル−10(注2) 0.04
[Example 11] Facial washing foam (1) Stearic acid 16.0 (mass%)
(2) Myristic acid 16.0
(3) Oil-based glycerin monostearate 2.0
(4) Glycerin 20.0
(5) Sodium hydroxide 7.5
(6) Coconut oil fatty acid amide propyl betaine 1.0
(7) Amount of purified water with 100 as a whole (8) Tranexamic acid 2.0
(9) Glyceryl glucoside (Note 1) 0.4
(10) (Icosanedioic acid / tetradecanedioic acid)
Polyglyceryl-10 (Note 2) 0.04
[実施例12]メイクアップベースクリーム
(1)スクワラン 10.0(質量%)
(2)セタノール 2.0
(3)グリセリントリ−2−エチルヘキサン酸エステル 2.5
(4)親油型モノステアリン酸グリセリル 1.0
(5)プロピレングリコール 11.0
(6)ショ糖脂肪酸エステル 1.3
(7)精製水 全量を100とする量
(8)酸化チタン 1.0
(9)ベンガラ 0.1
(10)黄酸化鉄 0.4
(11)香料 0.1
(12)トラネキサム酸 1.0
(13)グリセリルグルコシド(注1) 0.2
(14)2−メタクリロイルオキシエチルホスホリルコリン
・メタクリル酸ブチル共重合体液(注3) 0.01
[Example 12] Makeup base cream (1) Squalene 10.0 (mass%)
(2) Cetanol 2.0
(3) Glycerin tri-2-ethylhexanoic acid ester 2.5
(4) Oil-based glyceryl monostearate 1.0
(5) Propylene glycol 11.0
(6) Sucrose fatty acid ester 1.3
(7) Amount of purified water with 100 as a whole (8) Titanium oxide 1.0
(9) Bengala 0.1
(10) Iron yellow oxide 0.4
(11) Fragrance 0.1
(12) Tranexamic acid 1.0
(13) Glyceryl glucoside (Note 1) 0.2
(14) 2-methacryloyloxyethyl phosphorylcholine / butyl methacrylate copolymer solution (Note 3) 0.01
[実施例13]乳液状ファンデーション
(1)メチルポリシロキサン 2.0(質量%)
(2)スクワラン 5.0
(3)ミリスチン酸オクチルドデシル 5.0
(4)セタノール 1.0
(5)ポリオキシエチレン(20E.O.)
ソルビタンモノステアリン酸エステル 1.3
(6)モノステアリン酸ソルビタン 0.7
(7)1,3−ブチレングリコール 8.0
(8)キサンタンガム 0.1
(9)パラオキシ安息香酸メチル 0.1
(10)精製水 全量を100とする量
(11)酸化チタン 9.0
(12)タルク 7.4
(13)ベンガラ 0.5
(14)黄酸化鉄 1.1
(15)黒酸化鉄 0.1
(16)香料 0.1
(17)トラネキサム酸 1.0
(18)グリセリルグルコシド(注1) 0.2
(19)(エイコサン二酸/テトラデカン二酸)
ポリグリセリル−10(注2) 0.02
[Example 13] Emulsion foundation (1) Methylpolysiloxane 2.0 (mass%)
(2) Squalene 5.0
(3) Octyldodecyl myristate 5.0
(4) Cetanol 1.0
(5) Polyoxyethylene (20EO)
Sorbitan monostearic acid ester 1.3
(6) Sorbitan monostearate 0.7
(7) 1,3-butylene glycol 8.0
(8) Xanthan gum 0.1
(9) Methyl paraoxybenzoate 0.1
(10) Amount of purified water with 100 as a whole (11) Titanium oxide 9.0
(12) Talc 7.4
(13) Bengala 0.5
(14) Iron yellow oxide 1.1
(15) Black iron oxide 0.1
(16) Fragrance 0.1
(17) Tranexamic acid 1.0
(18) Glyceryl glucoside (Note 1) 0.2
(19) (Icosanedioic acid / tetradecanedioic acid)
Polyglyceryl-10 (Note 2) 0.02
[実施例14]油中水型エモリエントクリーム
(1)流動パラフィン 30.0(質量%)
(2)マイクロクリスタリンワックス 2.0
(3)ワセリン 5.0
(4)ジグリセリンオレイン酸エステル 5.0
(5)塩化ナトリウム 1.3
(6)塩化カリウム 0.1
(7)プロピレングリコール 3.0
(8)1,3−ブチレングリコール 5.0
(9)パラオキシ安息香酸メチル 0.1
(10)トラネキサム酸 2.0
(11)グリセリルグルコシド(注1) 0.2
(12)(エイコサン二酸/テトラデカン二酸)
ポリグリセリル−10(注2) 0.02
(13)精製水 全量を100とする量
(14)香料 0.1
[Example 14] Water-in-oil emollient cream (1) Liquid paraffin 30.0 (mass%)
(2) Microcrystalline wax 2.0
(3) Vaseline 5.0
(4) Diglycerin oleate 5.0
(5) Sodium chloride 1.3
(6) Potassium chloride 0.1
(7) Propylene glycol 3.0
(8) 1,3-butylene glycol 5.0
(9) Methyl paraoxybenzoate 0.1
(10) Tranexamic acid 2.0
(11) Glyceryl glucoside (Note 1) 0.2
(12) (Icosanedioic acid / tetradecanedioic acid)
Polyglyceryl-10 (Note 2) 0.02
(13) Amount of purified water with 100 as a whole (14) Fragrance 0.1
[実施例15]パック
(1)精製水 全量を100とする量(質量%)
(2)ポリビニルアルコール 12.0
(3)エタノール 17.0
(4)グリセリン 5.0
(5)ポリエチレングリコール(平均分子量1000) 2.0
(6)トラネキサム酸 1.0
(7)グリセリルグルコシド(注1) 0.2
(8)PEG/PPG/ポリブチレングリコール
−8/5/3グリセリン(注5) 0.2
(9)香料 0.1
[Example 15] Pack (1) Amount (mass%) with the total amount of purified water as 100
(2) Polyvinyl alcohol 12.0
(3) Ethanol 17.0
(4) Glycerin 5.0
(5) Polyethylene glycol (average molecular weight 1000) 2.0
(6) Tranexamic acid 1.0
(7) Glyceryl glucoside (Note 1) 0.2
(8) PEG / PPG / polybutylene glycol-8 / 5/3 glycerin (Note 5) 0.2
(9) Fragrance 0.1
[実施例16]シート状パック
(1)香料 0.1(質量%)
(2)1,3−ブチレングリコール 5.0
(3)グリセリン 5.0
(4)エタノール 3.0
(5)トラネキサム酸 1.0
(6)グリセリルグルコシド(注1) 0.2
(7)トリメチルグリシン(注4) 0.1
(8)PEG/PPG/ポリブチレングリコール
−8/5/3グリセリン(注5) 0.1
(9)精製水 全量を100とする量
[Example 16] Sheet pack (1) Fragrance 0.1 (mass%)
(2) 1,3-butylene glycol 5.0
(3) Glycerin 5.0
(4) Ethanol 3.0
(5) Tranexamic acid 1.0
(6) Glyceryl glucoside (Note 1) 0.2
(7) Trimethylglycine (Note 4) 0.1
(8) PEG / PPG / polybutylene glycol-8 / 5/3 glycerin (Note 5) 0.1
(9) Amount with 100 as the total amount of purified water
Claims (1)
(A)トラネキサム酸又はその塩
(B)グリセリルグルコシド
(C)二価カルボン酸及び平均重合度2以上15以下のポリグリセリンから構成されるオリゴマーエステル、ホスホリルコリン基含有重合体、トリメチルグリシン、並びに下記式(2)
Z−{O(AO)l(EO)m−(BO)nH}a …式(2)
(式中、
Zは3〜9個の水酸基を有する化合物の水酸基を除いた残基を表し;
AOは炭素数3〜4のオキシアルキレン基を表し;
EOはオキシエチレン基を表し;BOは炭素数4のオキシアルキレン基を表し;
aは3〜9を表し;
l、m及びnは、それぞれ、AO、EO及びBOの平均付加モル数であって、1≦l≦50、1≦m≦50及び0.5≦n≦5であり;
AOとEOとの重量比(AO/EO)は1/5〜5/1であり;
AO及びEOはランダム状又はブロック状に付加されてもよい。)
で表される少なくとも1つのアルキレンオキシド誘導体から選択される1種又は2種以上 An external preparation for skin containing the following (A) to (C).
(A) Tranexamic acid or a salt thereof (B) Glyceryl glucoside (C) Divalent carboxylic acid and an oligomer ester composed of polyglycerin having an average degree of polymerization of 2 or more and 15 or less, a phosphorylcholine group-containing polymer, trimethylglycine, and the following formula. (2)
Z- {O (AO) l (EO) m- (BO) n H} a ... Equation (2)
(During the ceremony,
Z represents the residue of the compound having 3 to 9 hydroxyl groups excluding the hydroxyl group;
AO represents an oxyalkylene group having 3 to 4 carbon atoms;
EO represents an oxyethylene group; BO represents an oxyalkylene group having 4 carbon atoms;
a represents 3-9;
l, m and n are the average number of moles of AO, EO and BO, respectively, 1 ≦ l ≦ 50, 1 ≦ m ≦ 50 and 0.5 ≦ n ≦ 5.
The weight ratio of AO to EO (AO / EO) is 1/5 to 5/1;
AO and EO may be added randomly or in blocks. )
One or more selected from at least one alkylene oxide derivative represented by
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020016095A JP7471098B2 (en) | 2020-02-03 | 2020-02-03 | Skin preparations |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020016095A JP7471098B2 (en) | 2020-02-03 | 2020-02-03 | Skin preparations |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021123540A true JP2021123540A (en) | 2021-08-30 |
JP7471098B2 JP7471098B2 (en) | 2024-04-19 |
Family
ID=77458123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020016095A Active JP7471098B2 (en) | 2020-02-03 | 2020-02-03 | Skin preparations |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7471098B2 (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2902998B1 (en) | 2006-07-03 | 2012-09-21 | Oreal | USE OF AT LEAST ONE C-GLYCOSIDE DERIVATIVE AS A SOOTHING AGENT |
JP6570186B2 (en) | 2014-03-31 | 2019-09-04 | カーリットホールディングス株式会社 | Glyceryl glucoside-containing composition and method for producing the same |
CN106456484A (en) | 2014-06-30 | 2017-02-22 | 乐敦制药株式会社 | External preparation |
JP6448377B2 (en) | 2015-01-16 | 2019-01-09 | 株式会社マンダム | Cleansing lotion |
JP6803732B2 (en) | 2016-11-28 | 2020-12-23 | 日本精化株式会社 | Cosmetics containing γ-oryzanol |
JP7126754B2 (en) | 2018-07-02 | 2022-08-29 | 株式会社ノエビア | Skin topical agent |
JP6416433B1 (en) | 2018-07-23 | 2018-10-31 | 株式会社ノエビア | Topical skin preparation |
-
2020
- 2020-02-03 JP JP2020016095A patent/JP7471098B2/en active Active
Non-Patent Citations (2)
Title |
---|
CLEAR-UP LOTION, MINTEL GNPD [ONLINE], 2018.07,[検索日 2023.11.27], JPN6023049081, ISSN: 0005210343 * |
WHITENING LOTION EX, MINTEL GNPD [ONLINE], 2018.03,[検索日 2023.11.27], JPN6023049082, ISSN: 0005210344 * |
Also Published As
Publication number | Publication date |
---|---|
JP7471098B2 (en) | 2024-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101539128B1 (en) | (meth)acrylic acid/alkyl (meth)acrylate ester copolymer and cosmetic preparation containing the same | |
KR102462218B1 (en) | Copolymer and oily gelling agent | |
KR101293347B1 (en) | Water-soluble copolymer having alkyl-modified carboxyl group | |
US8309667B2 (en) | Water-soluble copolymer having alkyl-modified carboxyl groups | |
JP4736112B2 (en) | Cosmetic base material and cosmetic comprising the same | |
US20060018863A1 (en) | Novel ethylenic copolymers, compositions and methods of the same | |
JPH11506133A (en) | Personal care compositions containing a hydrophobic linear copolymer and a hydrophobic volatile branched hydrocarbon solvent | |
JP2007217348A (en) | Thickener and cosmetic and cleaner containing the same | |
KR20030016223A (en) | Gel-form composition | |
JP2011026304A (en) | Copolymer for cosmetic, and composition for cosmetic containing the same | |
JP2000178123A (en) | Cosmetic substrate composition and cosmetic | |
JP6260111B2 (en) | Anti-wrinkle composition and cosmetic | |
KR101250585B1 (en) | Polymer compositions for cosmetics | |
JP7471098B2 (en) | Skin preparations | |
JP4312122B2 (en) | Cosmetics | |
JP5689323B2 (en) | Cosmetics | |
JP2021011458A (en) | External preparation for skin | |
WO2012057210A1 (en) | Copolymer and cosmetic material composition | |
JP5366581B2 (en) | Polymer composition | |
JP4297273B2 (en) | Cosmetics | |
JP2021134148A (en) | External preparation for skin | |
JP4808300B2 (en) | Polymer emulsion | |
JP7446861B2 (en) | moisturizer | |
KR20040064296A (en) | External preparation for the skin and copolymer to be used therein | |
JP2004237010A (en) | Coating type contact medium for ultrasonic diagnosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221116 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20231018 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231205 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240125 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240402 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240409 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7471098 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |